Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Gastroenterologia Y Hepatologia|September 17, 2022
Incidence, risk factors and clinical outcomes of multidrug-resistant microorganism infections among patients admitted for decompensated cirrhosis: A prospective studyHelena Masnou, Ariadna Aguilar, Ignacio Iborra, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 12, 2025
Hepatitis B and C Screening and Linkage to Care in Migrants From Endemic Countries in Barcelona Through a Community ActionAnna Not, Hakima Ouaarab-Essadek, Marcos Montoro, et al.
Antiviral Research|May 29, 2018
Large-scale screening of circulating microRNAs in individuals with HIV-1 mono-infections reveals specific liver damage signaturesSandra Franco, Daniela Buccione, Raquel Pluvinet, et al.
Journal of Gastroenterology and Hepatology|October 11, 2017
Potential drug-drug interactions of OMBITASVIR, PARITAPREVIR/ritonavir ± DASABUVIR ± ribavirin in clinical practiceElena González-Colominas, María-Carlota Londoño, Rosa M Morillas, et al.
The Journal of Clinical Psychiatry|November 2, 2010
Prophylactic treatment with escitalopram of pegylated interferon alfa-2a-induced depression in hepatitis C: a 12-week, randomized, double-blind, placebo-controlled trialCrisanto Diez-Quevedo, Helena Masnou, Ramon Planas, et al.
Clinical Endocrinology|May 20, 2011
A prospective study of lymphocyte subpopulations and regulatory T cells in patients with chronic hepatitis C virus infection developing interferon-induced thyroiditisBerta Soldevila, Núria Alonso, Maria J Martínez-Arconada, et al.
Lancet (London, England)|March 27, 2019
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trialCàndid Villanueva, Agustín Albillos, Joan Genescà, et al.
Journal of Hepatology|April 27, 2021
Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosisCàndid Villanueva, Agustín Albillos, Joan Genescà, et al.
Plos One|September 13, 2017
Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin studyMaría Buti, María L Manzano, Rosa M Morillas, et al.
Plos One|June 26, 2018
Correction: Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin studyMaría Buti, María L Manzano, Rosa M Morillas, et al.
Pageof 4